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1. Introduction 
With advances in endoscopic techniques and the widespread use, detection rates for early 
gastric carcinoma are increasing, and minimally invasive surgery becomes more important 
in the treatment. Minimally invasive surgery with less extensive dissection involves 
avoidance of unnecessary lymphadenectomy, leading to the reduction of postoperative 
morbidity and mortality rates and the improvement of postoperative quality of life without 
impairing recurrence-free survival. Sentinel node (SN) biopsy is useful to dissect lymph 
node (LN) rationally and to avoid unnecessarily extensive lymphadenectomy in surgery for 
gastric carcinoma, as has been established in breast cancer and melanoma (Krag et al., 1998; 
Morton, 1992; van der Veen et al., 1994; Veronesi et al., 1997). Thus, SN biopsy could be a 
promising method for the management of gastric carcinoma. The concept is based on the 
notion that SNs are the first lymph nodes to which cancer cells metastasize from the primary 
lesion (Sobin, 2003). The presence of tumor cells in SNs indicates that cancer cells may 
metastasize to downstream nodes. Conversely, the absence of metastatic tumor cells in SNs 
indicates that metastasis is unlikely in other nodes. However, a convenient and sensitive 
method useful for the detection of SNs of gastric carcinoma has not been standardized. 
Development of a convenient and sensitive method useful for the detection of SNs will 
enable surgeons to rationally determine the extent of LN dissection and to perform 
minimally invasive surgery (Krag et al., 1998; Morton, 1992; van der Veen et al., 1994; 
Veronesi et al., 1997). Several methods have been developed to detect SNs using radioactive 
materials or vital dyes, such as patent blue violet, isosulfan blue and indocyanine green in 
gastric carcinoma (Hayashi et al., 2003; Hiratsuka et al., 2001; Hundley et al., 2002; Ichikura 
et al., 2002; Isozaki et al., 2004; Karube et al., 2004; Kim, M.C. et al., 2004; Kitagawa & 
Kitajima, 2002; Lee et al., 2005; Miwa et al., 2003; Nimura et al., 2004; Osaka et al., 2004; Ryu 
et al., 2003; Simsa et al., 2003; Song et al., 2004; Tanaka et al., 2004). Although the sensitivity 
of these materials or dyes for the detection of SNs is high, sentinel node navigation surgery 
using dye- or radio-guided methods has not yet been widely performed in early gastric 
cancer, partly owing to false-negative results in detecting SNs with tumor cell metastases, or 
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due to their own inherent drawbacks, such as blurred visualization and/or legal restrictions 
(Hayashi et al., 2003; Hiratsuka et al., 2001; Ichikura et al., 2002; Kim, M.C. et al., 2004; 
Kitagawa & Kitajima, 2002; Miwa et al., 2003; Tanaka et al., 2004). Accordingly, standardized 
tracers remain to be determined.  
Photosensitizers are used for the treatment of various carcinomas in a remedy that is well 
known as photodynamic therapy (Fisher et al., 1995; Kvam et al., 1990; Sharman et al., 1999). 
Photosensitizing agents preferentially accumulate in tumor tissues, and elicit cytocidal 
effects on tumor cells when excited at a wavelength specific for each agent (Sharman et al., 
1999). Photodynamic therapy makes use of photosensitizers with these unique properties to 
achieve highly selective and localized treatment of various carcinomas (Sharman et al., 
1999). ATX-S10Na (II) is a hydrophilic chlorine derivative with a major absorption 
wavelength of approximately 670 nm, and emits red fluorescence when excited at its 
absorption wavelength. ATX-S10Na (II) has been developed as a second-generation 
photosensitizer, which is eliminated more rapidly from the body than previously known 
first-generation photosensitizers. Therefore, major adverse reactions such as skin 
photosensitivity have been markedly reduced, compared to those of the first generation 
photosensitizers (Matsumoto et al., 2003; Mori et al., 2000a, 2000b; Nakajima et al., 1992, 
1998). In addition, ATX-S10Na (II) has a high affinity and specificity for tumor tissues, and 
thereby selectively accumulates in tumor tissues (Matsumoto et al., 2003; Mori et al., 2000a, 
2000b; Nakajima et al., 1992, 1998). To our knowledge, our study was the first report that 
describes the use of a hydrophilic photosensitizer, ATX-S10Na (II), for the detection of SNs 
in orthotopic transplants of human gastric carcinoma (Koyama et al., 2007a).  
In the present chapter, we showed a novel fluorescence-guided imaging system to detect 
SNs using a photosensitizing agent, ATX-S10Na (II), as a novel fluorescent tracer, and its 
usefulness for a fluorescence-guided lymphatic mapping system in an animal model of 
human gastric carcinoma. In the model, human gastric carcinoma cells were implanted 
orthotopically into nude rats. ATX-S10Na (II) was injected subserosally into the primary 
tumor lesion, and visualized by a fluorescence spectrolaparoscope. ATX-S10Na (II) would 
serve as a novel tracer in sentinel node navigation surgery for gastric carcinoma.  
1.1 Concept of sentinel node 
The sentinel node (SN) is defined as the first lymph node (LN) to receive lymphatic drainage 
from a primary tumor, and therefore it is commonly accepted that SN is the first LN in 
which tumor cells from the primary lesion form lymphatic metastases (Sobin, 2003; Fig. 1). 
Detection of a metastatic tumor in the SN could mean metastasis of tumor cells to the 
downstream LNs. Conversely, absence of metastatic tumors in the SN indicates that the 
downstream LNs most likely do not contain metastatic tumor cells.  
2. Photosensitive fluorescent tracer 
ATX-S10Na (II) [13,17-bis(1-carboxypropionyl) carbamoylethyl-8-ethenyl-2-hydroxy-3- 
hydroxy-iminoethylidene-2,7,12,18-tetramethyl-prophyrin tetrasodium salt], is synthesized, 
purified and supplied by Photochemical Co. (Okayama, Japan). Its structure (C42H41N7Na4 
O12; molecular weight 927.77, Fig.2) and metabolism were described in detail previously 
(Matsumoto et al., 2003; Mori et al., 2000a, 2000b; Nakajima et al., 1992, 1998). When the 
photosensitizer is activated by irradiation with excitation light of 450±40 nm (mean ± SD), it 
emits a strong red fluorescence of 667 nm wavelength (Fig. 3). Therefore, we are able to 
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Fig. 1. Concept of sentinel node 
 
 
Fig. 2. Chemical structure of ATX-S10Na (II) 
 
 
Fig. 3. Basic principle of photosensitizer 
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detect the sentinel node by the red fluorescence of ATX-S10Na (II) which is injected at the 
primary tumor. The reagent is stored as a powder in the dark at -80˚C, and dissolved in 
phosphate-buffered saline to a final concentration of 5 mg/ml each time immediately before 
use. 
3. Orthotopic xenograft model of human gastric carcinoma 
3.1 Cell line 
The OCUM-2M LN cell line was originally derived from human scirrhous gastric carcinoma 
(Fujihara et al., 1998). This cell line forms LN metastases, when it is injected orthotopically 
into the stomach of athymic nude rats. Cells are cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% fetal calf serum, 100 U/ml penicillin, and 100 
mg/ml streptomycin in a humidified atmosphere containing 5% CO2 at 37˚C. The cells in 
the log phase of growth are washed twice with phosphate-buffered saline, treated with 
trypsin and collected by centrifugation. The cell pellets are dissolved in DMEM and 
adjusted at a concentration of 5×107 cells/ml. Cells are used in the experiments only when 
their viability exceeds 95%, as determined by the trypan blue dye-exclusion test.  
3.2 Tumor cell implantation 
Five- to seven-week-old female athymic nude rats (F344/N Jcl-rnu; CLEA Japan, Co., Tokyo, 
Japan) are housed in a temperature-controlled pathogen-free facility, maintained on a 12- 
hour light/12-hour dark cycle, and provided with commercially available rat chow and tap 
water ad libitum. Rats are pretreated by irradiation with 3 Gy of X-rays 3 days before tumor 
cell inoculation to reduce the number of active natural killer lymphocytes (Fig. 4). Rats are 
anesthetized for all procedures by an intraperitoneal injection of pentobarbital sodium (40 
mg/kg body weight), and then an incision is made in the upper abdominal median line. The 
stomach is exposed, and a total of 1×106 OCUM-2M LN cells in a volume of 20 μl of DMEM 
is injected subserosally into the middle anterior wall of the lesser curvature of the stomach 
with a 29-gauge needle. After the orthotopic implantation of tumor cells, the abdominal wall 
is sutured and closed using 6-0 surgical sutures. All procedures are performed in a patho- 
gen-free environment. To monitor the growth of inoculated tumor cells, sera are obtained by 
periorbital bleeding weekly, and the serum levels of CA19-9, a marker of tumor growth, are 
 
 
Fig. 4. Procedures of tumor cell implantation 
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measured by radioimmunoassay using a commercially available kit (Fujirebio, Inc., Tokyo). 
When the level of serum CA19-9 values increases above 6 units/ml, which is a sign of tumor 
growth, the presence of SNs is investigated with a fluorescence spectrolaparoscope. 
3.3 Establishment of orthotopic xenograft 
In our experiment, 95% of nude rats inoculated with tumor cells showed the establishment 
of orthotopic xenografts of human gastric carcinoma (Koyama et al, 2007a). The primary 
lesions of the implanted tumors grew up to the median size of 5.0 mm (range, 2.2–8.2 mm) 
by the largest diameter. In tumor-bearing rats, the median size of the left gastric LNs (Lg-
LNs) was 3.9 mm (range, 2.5-14.3 mm) in diameter. Fig. 5 shows a representative example of 
the primary lesion in the stomach and the enlarged Lg-LN. Subserosally inoculated OCUM-
2M LN cells developed into a solid tumor (“primary lesion”; Fig. 5, black arrowhead) at the 
middle anterior wall of the lesser curvature of the stomach. Enlarged Lg-LN (Fig. 5, white 
arrowhead), which had tumor metastases, was also observed. The corresponding Lg-LN 
specimen displays poorly differentiated adenocarcinoma, which is a characteristic feature of 
OCUM-2M LN, human scirrhous carcinoma of the stomach (Fig. 6; bar = 100 µm).  
To confirm the presence of tumor cells in LNs (LN metastasis), human β-actin was amplified 
specifically by cDNA synthesis of total RNA extracted from tissue samples and subsequent 
reverse transcriptase-polymerase chain reaction (RT-PCR). The LN metastases were 
histopathologically observed in 56% of tumor-bearing rats. These tissues were positive for 
human β-actin by RT-PCR (Koyama et al, 2007a). Control rats did not develop solid tumors 
and showed no changes in the lymphatic system.  
 
   
Fig. 5. Establishment of orthotopic xenograft model of human gastric carcinoma 
 
 
Fig. 6. Hematoxylin and eosin stain of left gastric lymph node 
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4. Detection of sentinel nodes by fluorescence spectrolaparoscope 
4.1 Fluorescence spectrolaparoscope 
Re-laparotomy is performed on tumor-implanted rats under general anesthesia, when 
serum CA19-9 concentrations increase above 6 units/ml. After an exposure of the stomach, 
ATX-S10Na (II) solution at a total volume of 40–60 μl is injected using a 29-gauge needle into 
the serosal side of the implanted tumor [Fig. 7(a)]. ATXS10Na (II) injected into the primary 
lesion is excited by the light of 450±40 nm [Fig. 7(b), 7(c) and 7(d)], which is emitted from the 
tip of the laparoscope equipped with a xenon lamp and a bandpass excitation filter of 
450±40 nm. ATX-S10Na (II) localized in tissues emits fluorescence of 667 nm, which is 
visualized using a bandpass emission filter of >510-nm. The emission filter is useful for 
blocking the excitation light and other components such as natural autofluorescence of the 
surrounding tissues. An image-intensified charge-coupled device (CCD) camera is 
furnished with two built-in filters, a conventional white-light filter and an emission filter of 
>510-nm, and is attached to the ocular end of the laparoscope through the adaptor. The 
dynamic image of excited ATX-S10Na (II) is monitored in real-time on an RGB display via an 
image processing system, and recorded on a camcorder with 192×104 pixels for 60 minutes 
after the injection. The intensity and exposure time of the excitation light are constant 
throughout these experiments. 
4.2 Dynamic imaging and distribution of photosensitizer 
Fluorescence distribution of ATX-S10Na (II) in the abdomen is visualized as vivid red color 
on the imaging board using the spectrolaparoscope. In tumor-bearing rats, ATX-S10Na (II) 
solution is injected into the tumor of primary lesion via stomach serosa using a 29-gauge 
syringe [Fig. 7 (a); white arrowhead]. The red-fluorescent ATX-S10Na (II) is clearly identified 
and uptaken rapidly into the lymphatic tissue around the primary lesion [Fig. 7 (b)]. 
Subsequently, the red-emitting fluorescence is incorporated rapidly into the Lg-LN [Fig. 7 
(c) and (d); white arrowhead] through the afferent lymphatic vessels [Fig. 7 (c) and (d); 
white arrows]. The migration of ATX-S10Na (II) takes place within a period of 5 minutes of 
the injection. The fluorescence intensity increases, reaching a peak and plateau 
approximately at 1–9 minutes, and persists without attenuation during the entire observa- 
tion time. In contrast, no or little fluorescence is detected in the surrounding non-lymphatic 
tissues. The contrast between the red fluorescent tissues and non-fluorescent area is distinct, 
and all investigators can identify the red fluorescent nodes easily. In control rats, fluorescent 
dye is incorporated rapidly into the lymph vessels around the injection site, migrates 
through them and disappears within 3 minutes. Of note, none of the LN is stained with the 
fluorescence in the control rats. 
4.3 Sentinel nodes and nodal metastases 
According to the sentinel node (SN) concept, the first LN into which ATX-S10Na (II) flows is 
regarded as the “SN”. Fig. 8 shows an example in which ATX-S10Na (II) was incorporated 
rapidly into afferent lymphatic vessels around the primary lesion, lymphatic network, and 
flowed first into the Lg-LN. Thus, the Lg-LN was regarded as the SN. The Lg-LN was 
occupied with tumor cell metastases, showing poorly differentiated adenocarcinoma with a 
characteristic feature of OCUM-2M LN, human scirrhous carcinoma of the stomach [Fig. 8 
(d); hematoxylin and eosin stain], and was visualized by the red-fluorescence of ATX-S10Na 
(II) [Fig. 8 (a), (b) and (c)]. The incision was made in the isolated red-fluorescent Lg-LN at 
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(a) Injection of ATX-S10Na (II)                 (b) Uptake into lymphatic tissue 
    
(c) Visualization of lymph nodes               (d) Visualization of lymph nodes 
Fig. 7. Detection of lymphatic tissues by ATX-S10Na (II) 
the dotted line [Fig. 8 (b)], and the uptake of red fluorescence into metastatic lesion was 
observed as shown in Fig. 8 (c) and (d). We provisionally termed the red-fluorescent LNs 
“red nodes’’, similar to those designated as ‘‘blue or green nodes’’ using vital dyes (Hayashi 
et al., 2003; Hiratsuka et al., 2001; Ichikura et al., 2002) or ‘‘hot nodes’’ using radioactive 
particles (Hayashi et al., 2003).  
After the completion of each experiment, the Lg-LN (SN) was separated, and the other LNs 
located downstream of Lg-LN or SN, including the hepatic, splenic and pancreatico- 
duodenal LNs, were harvested en bloc. In all LN samples dissected, the presence of human 
β-actin mRNA was investigated by RT-PCR to assess the presence of metastases of tumor 
cells (Koyama et al., 2007a). In 25 out of 27 rats, ATX-S10Na (II) was incorporated into the 
Lg-LN (SN), which was identified as a red node. Of note, human β-actin was positive in 24 
out of these 25 red nodes (SNs). To our surprise, human β-actin was also positive in all LNs 
located downstream of human-β-actin-positive red-fluorescent Lg-LNs (SNs) in these 24 
rats. In contrast, human β-actin was negative in the downstream LNs of the rat with a 
human-β-actin-negative red-fluorescent Lg-LN (SN). In the remaining 2 out of 27 rats, the 
ATX-S10Na (II) was incorporated into the hepatic LNs (SNs), but not into the Lg-LN (non-
SN). Therefore, the hepatic LN but not the Lg-LN was identified as a red node (SN) in these 
two rats. Interestingly, both of the two non-red Lg-LNs (non-SNs) were negative for human 
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(a) Uptake of ATX-S10Na (II)                  (b) Incision into isolated Lg-LN 
   
(c) Incised side of isolated Lg-LN              (d) Histopathological findings 
Fig. 8. Lymph nodes detected by ATX-S10Na (II) 
β-actin, whereas both of the two red-fluorescent hepatic LNs (SNs) were positive for human 
b-actin. On the single-section specimens, 19 human-β-actin-positive red-fluorescent Lg-LNs 
were poorly differentiated adenocarcinoma, and others showed no malignant findings. In 
control rats, human β-actin was negative in both Lg-LNs and other LNs.  
 
 
Fig. 9. Uptake of ATX-S10Na (II) in Case 1         
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Fig. 10. Uptake of ATX-S10Na (II) in Case 2 
 
 
Fig. 11. Isolation of red-emitting Lg-LN stained with ATX-S10Na (II) 
In another two examples (Fig. 9 and 10), red-fluorescent ATX-S10Na (II) was incorporated 
rapidly into afferent lymphatic vessels around the primary lesion, lymphatic network, and 
flowed first into the Lg-LN. The lymph nodes as well as afferent lymphatic vessels were 
visualized vividly by this method. Although Case 2 (Fig. 10) was bleeding heavily during 
experiment, red-emitting LNs were detected easily. After the completion of observation, a 
red- emitting Lg-LN with metastasis of poorly differentiated adenocarcinoma was harvested 
and dissected in Case 1 (Fig. 11). The LN continued to emit red fluorescence in the similar 
degree of intensity at least for 30 minutes. Thus, ATX-S10Na (II) could efficiently visualize 
lymphatic network around the primary lesion, afferent lymphatic vessel and sentinel node. 
This method is simple and convenient, since it dose not require radioisotope or gamma probe. 
5. Advantage of photosensitizer to tracer 
5.1 Visualization of sentinel nodes by strong emission of red fluorescence 
ATX-S10Na (II) emits strong red fluorescence with excitation wavelength (Nakajima et al., 
1998). As shown in Fig. 7 to 10, the distribution of ATX-S10Na (II) in lymphatic network can 
be detected clearly and easily by the red fluorescence marking. This photographic 
visualization allows any observer to clearly identify SNs, and to easily determine the 
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location and orientation of SNs in the orthotopic xenograft animal model. Such direct real-
time visualization is not possible using radioactive tracers, which must be measured by 
scintillation probes or gamma camera (Hayashi et al., 2003; Kim et al., 2004; Kitagawa & 
Kitajima, 2002; Tanaka et al., 2004). Of note, this novel procedure would be easily conducted 
in human and in community hospitals without difficulties, because it does not require 
complicated procedures, special facilities or radioactive substances. Other non-fluorescent 
dye tracers (Hiratsuka et al., 2001; Ichikura et al., 2002; Hayashi et al., 2003; Miwa et al., 
2003; Tanaka et al., 2004) cannot provide such a vivid and colorful contrast. The visual and 
technical advantage of ATX-S10Na (II) may assist every surgeon to assess SNs accurately in 
sentinel node navigation surgery, and potentially prevent an oversight for false-negative 
LNs.  
5.2 Rapid incorporation into lymphatic tissues 
As a general rule, photosensitizers are systemically administered via a peripheral intrave- 
nous route before laser irradiation in photodynamic therapy for various carcinomas. As 
shown in Fig. 7, however, ATX-S10Na (II) is incorporated rapidly into lymphatic tissues after 
subserosal injection into the primary tumor. Our study confirmed for the first time that 
ATX-S10Na (II) is taken up by local lymphatic tissues when it is subserosally injected into 
the primary tumor lesion (Koyama et al., 2007a). One possible explanation for the 
phenomenon is that the chemical structure of ATX-S10Na (II) is water-soluble, but not lipid-
soluble (Matsumoto et al., 2003; Mori et al., 2000a, 2000b; Nakajima et al., 1992, 1998). Since 
the uptake of ATX-S10Na (II) into lymphatic system is rapid and its fluorescence can be 
consistently observed in real time, this approach appears to be useful for shortening the time 
required for SN biopsy and surgical procedure. Of importance, the ATX-S10Na (II)-guided 
method is not associated with the “shine-through’’ phenomenon, whereby the large hot spot 
at the injection site of radioactive tracers disturbs the detection of SNs around the primary 
tumor lesion.  
5.3 High affinity and specific uptake to tumor cells 
ATX-S10Na (II) is a high affinity molecule for tumor cells. Its preferential uptake in target 
tumor cells results in selective accumulations in tumor tissues, indicating that the tumor- 
specificity of photodynamic therapy depends largely on the oncotropic properties of photo- 
sensitizers (Fisher et al., 1995; Kvam et al., 1990; Matsumoto et al., 2003; Mori et al., 2000a, 
2000b; Nakajima et al., 1992, 1998; Sharman et al., 1999). As shown in Fig. 8, ATX-S10Na (II) 
can be taken up by LNs that are involved with tumor metastases. However, the precise 
mechanisms of tumor-specific uptake of ATX-S10Na (II) remain unclear. It is proposed that 
ATX-S10 Na (II) is incorporated into tumor cells by fluid phase endocytosis, receptor-
mediated endocytosis, or orphan transporters (Mori et al., 2000b). Alternatively, another 
possible mechanism is that lymphatic flow is delayed or altered in LNs filled with metastatic 
tumor cells, resulting in preferential retention of ATX-S10Na (II) in such LNs. In our 
previous study, the presence of tumor metastases in LNs was assessed by RT-PCR of human 
β-actin (Koyama et al., 2007a). To our surprise, human β-actin was positive in all LNs 
located downstream of human-β-actin-positive Lg-LN that was regarded as SN. In contrast, 
LNs located downstream of human-β-actin-negative Lg-LN (SN) were negative for human 
β-actin. In addition, all human-β-actin-positive Lg-LNs (SNs) were red nodes, whereas all 
non-red Lg-LNs (non-SNs) were human β-actin-negative. Considering the higher positive 
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rates by RT-PCR assay than conventional histopathological examination (Bilchik et al., 2001; 
Kitagawa & Kitajima, 2002; Maruyama et al., 1999; Natsugoe, et al., 1998; Noura et al., 2002), 
these results showed high sensitivity and specificity of the ATX-S10Na (II)-guided method 
for the detection of SNs. Because micrometastasis occurs frequently in gastric carcinoma, the 
system using ATXS10Na (II) may be a novel technology to detect micrometastases with high 
sensitivity, resulting in reduction of false-negative LNs. 
5.4 Little toxicity in human 
No obvious toxicity was observed in rats that were injected locally with ATX-S10Na (II) at a 
dose of 1.3–2.5 mg/kg in our study (Koyama et al., 2007a). This dosage is much smaller than 
that of systemic administration given intravenously at a dose of 5–25 mg/kg, which caused 
little, if any, toxicity in vivo (Matsumoto et al., 2003; Mori et al., 2000a; Nakajima et al., 1992, 
1998). Since ATX-S10Na (II) is a hydrophilic photosensitizer with a low-molecular weight, its 
clearance from tissues and body (within 24 hours) is much faster than that of the first 
generation photosensitizers. Therefore, it has substantially less adverse effects (Matsumoto 
et al., 2003; Mori et al., 2000a; Nakajima et al., 1992; Nakajima et al., 1998). We acknowledge 
that our studies were conducted in an orthotopic xenograft rat model (Koyama et al, 2007a, 
2007b), in which the structure and anatomy of the regional lymphatic network may be 
different from those of human system (Ichikura et al., 2002; Miwa et al., 2003). Alternatively, 
the rat model may not be comparable to early gastric carcinoma in humans, for which 
sentinel node navigation surgery is more suitable (Hiratsuka et al., 2001; Isozaki et al., 2004). 
Clear visualization of lymphatic system by ATX-S10Na (II) may be only true of the animal 
model. However, our studies do demonstrate the potential usefulness of ATX-S10Na (II) as a 
tracer of SNs by assessing tumor metastases with RT-PCR (Koyama et al., 2007a, 2007b). In 
25 out of 27 rats, Lg-LN (SN) was identified as a red node, and most of these Lg-LNs (SNs) 
were positive for human β-actin, which was an indication of tumor metastasis. Of interest, 
ATX-S10Na (II) was incorporated into the hepatic LN (SN), but not into the Lg-LN (non-SN) 
in two out of 27 rats, and human β-actin was positive only in the hepatic LN (SN), but not in 
the Lg-LN (non-SN) in these rats. These findings support the notion that SN is the first LN 
to receive lymphatic drainage and tumor cells from a primary tumor, and ATX-S10Na (II) is 
useful for the detection of SNs. 
6. Other dye tracers and comparison with ATX-S10Na (II) 
Patent blue violet (Hayashi et al., 2003; Karube et al., 2004; Miwa et al., 2003; Simsa et al., 
2003), isosulfan blue (Hundley et al., 2002; Isozaki et al., 2004; Lee et al., 2005; Osaka et al., 
2004; Ryu et al., 2003; Song t al., 2004) and indocyanine green (ICG) (Hiratsuka et al., 2001; 
Ichikura et al., 2002; Nimura et al., 2004) have been used as vital dye tracers for the detection 
of SNs in gastric carcinoma. The detection rates of SNs were 72–96%, 91–100% and 99–100%, 
respectively. These favorable results must be carefully interpreted because SN mapping is 
dependent on the technical learning curve and skills of the surgeon (Ichikura et al., 2002; 
Simsa et al., 2003; Nimura et al., 2004). The sensitivity was 77–90%, 46–100% and 64–90%, 
respectively, suggesting that non-SNs could contain tumor cell metastases. In most of these 
reports, the presence of metastasis in LNs was determined by conventional haematoxylin 
and eosin staining. False-negative rates may increase when more sensitive methods such as 
multiple sectioning, immunohistochemical staining or RT–PCR technique are used.  
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Some biomedical imaging techniques use the characteristic feature of ICG; this dye absorbs 
infrared rays, which enhances its visibility (Flower & Hochheimer, 1976; Kohso et al., 1990). 
Enhanced visualization of ICG by using a near-infrared endoscopy substantially improves 
the rate of SN detection in patients with gastric carcinoma, compared with the use of ICG 
alone (Nimura et al., 2004). Interestingly, SNs illuminated with a near-infrared endoscope 
are clear enough to be identified by all observers, whereas SNs stained by ICG alone are not 
always visible to all investigators. As a result, the ICG-guided method combined with a 
near- infrared endoscope was reported to increase the sensitivity significantly from 64% of 
patients and 50% of LNs to 100% and 100%, respectively (Nimura et al., 2004). The combi- 
nation method appears to be a promising approach for biomedical imaging in living 
tissue.  
As shown in Fig. 7 to 10, the rapid migration of ATX-S10Na (II) along the lymphatic system 
is clearly visualized and easily identified in real time by the strong red fluorescence. Such 
visualization is clearer than that of enhanced visualization of ICG with a near-infrared 
laparoscope (Koyama et al., 2007b). Since a much darker operating room is required to 
ensure the detection of ICG through a near-infrared endoscopy, it may be difficult to 
perform other procedures. One explanation for the high-quality visualization of ATX-S10Na 
(II) is that the excitation wavelength peak (450 ± 40 nm) is completely separate from the 
emission wavelength peak (667 nm). With the visual advantage of ATX-S10Na (II), SNs 
would not be missed, and the time required for the surgical procedure may be shortened. 
In a comparative study using an orthotopic xenograft rat model, there was no significant 
difference in the detection rates of SNs, the sensitivity, and the number of stained nodes 
between ATX-S10Na (II) - and enhanced ICG-guided methods (Koyama et al., 2007b). These 
results suggest that the ATX-S10Na (II)-guided method is comparable to or possibly superior 
to the enhanced ICG-guided method. In addition, the number of ICG-stained nodes varies 
widely, since the number and distribution of stained nodes become larger and wider as the 
injection dose is increased (Ichikura et al., 2002). In the dual-mapping technique with dye 
and radioactive tracers, significant differences in distributions are noted between the two 
tracers (Hayashi et al., 2003; Karube et al., 2004). These findings raise the question of 
whether dye or radioactive traces flow into the lymphatic system in the same manner as 
metastatic cancer cells. ATX-S10Na (II) may resolve the issue, because it has a high 
specificity and affinity for tumor cells (Nakajima et al, 1992, 1998; Mori et al., 2000b). In the 
future, novel fluorescence-based reagents (Kim, S. et al., 2004; Ueno et al., 2005), including 
photosensi- tizers, will be developed as tracers that improve diagnostic accuracy in sentinel 
node navigation surgery.  
7. Conclusion 
A novel system using a hydrophilic photosensitizer ATX-S10Na (II) in combination with a 
fluorescence spectrolaparoscope is useful for the detection of cancer-containing sentinel 
nodes in an orthotopic xenograft animal model of human gastric carcinoma. ATX-S10Na (II) 
would serve as a novel tracer in sentinel node navigation surgery. This system has great 
potential application for the decision of minimally invasive surgery without radical 
extensive regional lymphadenectomy in early gastric carcinoma. A comparative study of 
ATX-S10Na (II) versus other dye tracers will determine whether the red-fluorescent tracer 
system is useful for lymphatic mapping in sentinel node navigation surgery for patients 
with early gastric carcinoma. 
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